Parkinson’s podcast: L-dopa – waiting for the next act

Resources & Tools

Author: Geoffrey ChangPublished: 18 February 2016

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

Why has it taken so long to improve levodopa – AKA L-dopa – delivery so that Parkinson’s patients can experience the drug’s benefit in a more continuous fashion?


In the latest Portland Countdown podcast, regular hosts Dave Iverson and Jon Palfreman invite special guest Dr Angela Cenci Nilsson to discuss how the landscape has changed since levodopa, or ‘dopamine-replacement’ therapy, was first developed 50 years ago – and today’s prospects for what was the first major breakthrough in Parkinson’s treatments.

While it’s undoubtedly a life-changing help for patients, levodopa isn’t a cure. The podcast explores why it has taken so long to improve its effectiveness or to develop the next breakthrough treatment. The panel also discuss the challenges of convincing big pharmaceutical companies to invest in these types of treatments.

The aim of the Portland Countdown series is to give listeners new perspectives on the latest advances in Parkinson’s research and treatment.

The shows, developed by the World Parkinson Coalition, are aired online on the first Tuesday of every month from June 2015 to September 2016 – when the 4th World Parkinson Congress takes place in Portland, Oregon, US. The podcasts are free and available for download.


The full schedule of show topics and guest speaker profiles is available here

Go Back

Share this story

Comments


Related articles


Global update

Think twice: the deadly risk of fake drugs

Learn how to how to tell a fake pill from a real one

READ MORE
Tonya Walker The Shoe Maven lead

Interviews

Standing tall: the fashion blogger and young onset campaigner who’s back in heels (thanks to DBS)

Tonya Walker, fashion blogger and young onset Parkinson's campaigner

READ MORE
Boston Scientific

sponsored article

Advances

Better results and fewer side effects with personalised DBS Therapy

Ongoing studies: better results in DBS with innovative technology

READ MORE